Published in Mol Carcinog on November 01, 2000
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition. Proc Natl Acad Sci U S A (2008) 1.80
PPARalpha deficiency in inflammatory cells suppresses tumor growth. PLoS One (2007) 1.24
ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARalpha -mediated inhibition of glioma cell motility in vitro. Mol Cancer (2010) 1.15
Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) (2010) 1.09
PPARs Mediate Lipid Signaling in Inflammation and Cancer. PPAR Res (2008) 0.96
Inhibition of peroxisome proliferator-activated receptor (PPAR)-mediated keratinocyte differentiation by lipoxygenase inhibitors. Biochem J (2002) 0.91
Peroxisome proliferator-activated receptors (PPARs) in dermatology: Challenge and promise. Dermatoendocrinol (2011) 0.90
PPARalpha Ligands as Antitumorigenic and Antiangiogenic Agents. PPAR Res (2008) 0.90
Mice lacking epidermal PPARγ exhibit a marked augmentation in photocarcinogenesis associated with increased UVB-induced apoptosis, inflammation and barrier dysfunction. Int J Cancer (2012) 0.88
Role of peroxisome proliferator-activated receptor alpha in the control of cyclooxygenase 2 and vascular endothelial growth factor: involvement in tumor growth. PPAR Res (2008) 0.85
PPAR Ligands for Cancer Chemoprevention. PPAR Res (2008) 0.83
Inhibition of conjugated linoleic acid on mouse forestomach neoplasia induced by benzo (a) pyrene and chemopreventive mechanisms. World J Gastroenterol (2003) 0.81
The Role of PPARs in the Endothelium: Implications for Cancer Therapy. PPAR Res (2008) 0.81
PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1. Pflugers Arch (2010) 0.79
PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes. PPAR Res (2008) 0.77
The peroxisome proliferator-activated receptor gamma system regulates ultraviolet B-induced prostaglandin e(2) production in human epidermal keratinocytes. PPAR Res (2010) 0.77
Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. Proc Natl Acad Sci U S A (1980) 1.94
Studies on mechanism of action of anti-tumor-promoting agents: their specificity in two-stage promotion. Proc Natl Acad Sci U S A (1980) 1.47
Evidence that the centrally and peripherally located cells in the murine epidermal proliferative unit are two distinct cell populations. J Invest Dermatol (1985) 1.47
15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst (2000) 1.43
Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem J (2001) 1.42
Evidence that a slowly cycling subpopulation of adult murine epidermal cells retains carcinogen. Cancer Res (1986) 1.41
15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31
Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J Lipid Res (1999) 1.30
Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene (2006) 1.26
Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem (1998) 1.24
Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst (1999) 1.23
Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res (2001) 1.22
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest (1995) 1.22
Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene (1993) 1.22
Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem Biophys Res Commun (1998) 1.20
Overexpression of the prostaglandin E2 receptor EP2 results in enhanced skin tumor development. Oncogene (2006) 1.13
Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene (1997) 1.08
Studies on the mechanisms involved in multistage carcinogenesis in mouse skin. J Cell Biochem (1982) 1.07
Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod (1997) 1.04
Separation of epidermal cells by density centrifugation: a new technique for studies on normal and pathological differentiation. J Cutan Pathol (1982) 1.03
Prostaglandin E(2) regulation of cyclooxygenase expression in keratinocytes is mediated via cyclic nucleotide-linked prostaglandin receptors. J Lipid Res (2000) 1.03
Conjugated linoleic acid activates peroxisome proliferator-activated receptor alpha and beta subtypes but does not induce hepatic peroxisome proliferation in Sprague-Dawley rats. Biochim Biophys Acta (1999) 1.01
Elevated expression and point mutation of the Ha-ras proto-oncogene in mouse skin tumors promoted by benzoyl peroxide and other promoting agents. Carcinogenesis (1987) 1.01
Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol (1997) 1.00
Subpopulations of primary adult murine epidermal basal cells sedimented on density gradients. Cell Tissue Kinet (1990) 1.00
The role of the EP receptors for prostaglandin E2 in skin and skin cancer. Cancer Metastasis Rev (2011) 0.99
Optimal fluorescence excitation wavelengths for detection of squamous intra-epithelial neoplasia: results from an animal model. Opt Express (2000) 0.98
Coordinated changes in cell cycle machinery occur during keratinocyte terminal differentiation. Oncogene (1999) 0.97
Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.97
Distribution of conjugated linoleic acid and metabolites in different lipid fractions in the rat liver. J Lipid Res (2001) 0.97
IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin. Cell Death Differ (2011) 0.96
The effect of vitamin E acetate on ultraviolet-induced mouse skin carcinogenesis. Mol Carcinog (1998) 0.96
[Trichosporon capitatum septicemia in immunosuppressed patients]. Pathol Biol (Paris) (1990) 0.95
Strain differences and solvent effects in mouse skin carcinogenesis experiments using carcinogens, tumor initiators and promoters. Prog Exp Tumor Res (1983) 0.95
Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obes Metab (2006) 0.94
Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Mol Carcinog (1998) 0.94
Epidermal proliferation but not quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Invest Dermatol (1997) 0.93
8S-lipoxygenase products activate peroxisome proliferator-activated receptor alpha and induce differentiation in murine keratinocytes. Cell Growth Differ (2000) 0.92
Physiological and genetic properties of tomato fruits from 2 cultivars differing in chilling tolerance at cold storage. J Food Sci (2009) 0.92
Effects of anti-promoters and strain of mouse on tumor promoter-induced oxidants in murine epidermal cells. Carcinogenesis (1986) 0.91
Fluorescence spectroscopy of epithelial tissue throughout the dysplasia-carcinoma sequence in an animal model: spectroscopic changes precede morphologic changes. Lasers Surg Med (2001) 0.90
Mitochondrial respiratory uncoupling promotes keratinocyte differentiation and blocks skin carcinogenesis. Oncogene (2012) 0.90
Suppression of tumor promoter-induced chemiluminescence in mouse epidermal cells by several inhibitors of arachidonic acid metabolism. Cancer Res (1985) 0.89
Quantitation of primary in vitro clonogenic keratinocytes from normal adult murine epidermis, following initiation, and during promotion of epidermal tumors. Cancer Res (1988) 0.89
Frequent allelic imbalance and loss of protein expression of the DNA repair gene hOGG1 in head and neck squamous cell carcinoma. Lab Invest (2001) 0.88
Acidic fibroblast growth factor (HBGF-1) stimulates DNA synthesis in primary rat hepatocyte cultures. J Cell Physiol (1990) 0.88
Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event. Braz J Med Biol Res (2010) 0.87
Temporal relationship between rabbit uterine epithelium proliferation and uteroglobin production. Biol Reprod (1981) 0.87
Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia. FASEB J (1994) 0.87
Metabolic conversion of 12-O-tetradecanoylphorbol-13-acetate in adult and newborn mouse skin and mouse liver microsomes. Cancer Res (1978) 0.86
Dental condition of two tribes of Taiwan aborigines--Ami and Atayal. J Dent Res (1977) 0.85
Specificity and mechanism(s) of promoter inhibitors in multistage promotion. Carcinog Compr Surv (1982) 0.85
Temporal distributions of problem behavior based on scatter plot analysis. J Appl Behav Anal (1998) 0.85
Dietary conjugated linoleic acid modulation of phorbol ester skin tumor promotion. Nutr Cancer (1996) 0.85
Skin-tumor-initiating ability of benzo(a)pyrene-7,8-diol-9,10-epoxide (anti) when applied topically in tetrahydrofuran. Cancer Lett (1977) 0.85
Events associated with mouse skin tumor promotion with respect to arachidonic acid metabolism: a comparison between SENCAR and NMRI mice. Cancer Res (1987) 0.85
MNU induction of neoplasia in a platyfish model. Lab Invest (2001) 0.84
FAB-MS/MS spectrometry in determining the primary structure of gamma-glutamyl-containing peptides. Agric Biol Chem (1990) 0.84
Evaluation of the effects of dietary fat, conjugated linoleic acid, and ractopamine on growth performance, pork quality, and fatty acid profiles in genetically lean gilts. J Anim Sci (2006) 0.84
Genetic analysis of neoplasia induced by N-nitroso-N-methylurea in Xiphophorus hybrid fish. Mar Biotechnol (NY) (2001) 0.84
Eicosapentaenoic and arachidonic acid: comparison of metabolism and activity in murine epidermal cells. Lipids (1989) 0.83
Signal transduction pathway(s) involved in phorbol ester and autocrine induction of interleukin-1 alpha mRNA in murine keratinocytes. J Biol Chem (1994) 0.83
Changes in protein expression during multistage mouse skin carcinogenesis. Mol Carcinog (1997) 0.83
Bilateral aldosterone-producing adenomas: differentiation from bilateral adrenal hyperplasia. QJM (2008) 0.83
Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. Eur J Cancer (1999) 0.83
Ultraviolet-B irradiation alters the cell cycle machinery in murine epidermis in vivo. J Invest Dermatol (2001) 0.83
A retrospective review on atypical glandular cells of undetermined significance (AGUS) using the Bethesda 2001 classification. Gynecol Oncol (2003) 0.83
Improved conditions for murine epidermal cell culture. In Vitro (1980) 0.83
Explant methods for epidermal cell culture. Methods Cell Biol (1980) 0.82
Identification and characterization of several forms of phospholipase A2 in mouse epidermal keratinocytes. J Lipid Res (1998) 0.82
Induction and inhibition of tumor progression. Proc Soc Exp Biol Med (1993) 0.82
Signal enhancement for gradient reverse-phase high-performance liquid chromatography-electrospray ionization mass spectrometry analysis with trifluoroacetic and other strong acid modifiers by postcolumn addition of propionic acid and isopropanol. J Am Soc Mass Spectrom (1995) 0.82
Regulation of adipose triglyceride lipase by rosiglitazone. Diabetes Obes Metab (2008) 0.82
Hepatocellular carcinoma following renal transplantation: experience in northern Taiwan. Transplant Proc (2008) 0.82
Intermittent 50 Hz magnetic field and skin tumor promotion in SENCAR mice. Carcinogenesis (1994) 0.82
Tumor-promoting activity of 2,4-dinitrofluorobenzene. Int J Cancer (1995) 0.81
An analysis of 100 primary cadaver kidney transplants. J Urol (1980) 0.81
Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis (1987) 0.81
Suppression of altered hepatic foci development by a high fish oil diet compared with a high corn oil diet in rats. Nutr Cancer (2000) 0.81
Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene. Carcinogenesis (1995) 0.81
Association of protein kinase C activation with induction of ornithine decarboxylase in murine but not human keratinocyte cultures. Mol Carcinog (1993) 0.80
Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int (2001) 0.80
Early induction of the arachidonic acid cascade and stimulation of DNA synthesis by TPA in murine and guinea pig epidermal cells in culture. Carcinog Compr Surv (1982) 0.80
Role of intracellular interleukin-1 receptor antagonist in skin carcinogenesis. Mol Carcinog (2001) 0.80
Deregulated expression of cyclin D1 overrides antimitogenic signals. Oncogene (2000) 0.80
Modulation of interleukin-1 alpha mRNA expression in mouse epidermis by tumor promoters and antagonists. Mol Carcinog (1993) 0.80
Altered expression of transforming growth factor-beta 1 mRNA and protein in mouse skin carcinogenesis. Mol Carcinog (1994) 0.80
Multistage chemical carcinogenesis in mouse skin. Curr Probl Dermatol (1980) 0.80
Arachidonic acid metabolism varies with the state of differentiation in density gradient-separated mouse epidermal cells. J Invest Dermatol (1990) 0.80
Species differences in the metabolism and regulation of gene expression by conjugated linoleic acid. Nutr Rev (1999) 0.80
In vitro transformation of epidermal cells from newborn mice. Cancer Res (1978) 0.80
Qualitative and quantitative separation of a series of phorbol-ester tumor promoters by high-pressure liquid chromatography. Cancer Lett (1977) 0.79
The oral signs of Hurler-Hunter syndrome: report of four cases. ASDC J Dent Child (1980) 0.79
Prostaglandin enhancement of skin tumor initiation and promotion. Adv Prostaglandin Thromboxane Res (1980) 0.79
Regulation of hepatocyte growth: alpha-1 adrenergic receptor and ras p21 changes in liver regeneration. J Cell Physiol (1989) 0.79